-
Anesthesia Drugs Market Poised for Robust Growth, Expected to Reach USD 8.6 Billion by 2032
29 Jan 2025 15:12 GMT
… treatments like heart-bypass surgeries. Essential medicines … Takeda Pharmaceuticals – (Dexmedetomidine hydrochloride, Ondansetron hydrochloride)
• AbbVie – (Dexmedetomidine hydrochloride, Ondansetron hydrochloride … Drugs Market by Drug
8. Anesthesia Drugs …
-
Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
29 Jan 2025 14:00 GMT
… registration trials for AD04 and conform with the FDA’s … the study confirmed that ondansetron pharmacokinetic exposure increased … launch. About Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals is a clinical … on the development of treatments for addictions and …
-
EXCLUSIVE: Adial Pharmaceuticals Reveals Positive Pharmacokinetics Study Results Of AD04 For Alcohol Use Disorder
29 Jan 2025 14:32 GMT
… food effect.
Results confirmed ondansetron exposure increased proportionally across … food.
Related: Adial Pharmaceuticals Reveals Topline Results From … GG), which may enhance drug binding and efficacy. … the ONWARD trial and planned for future FDA approval and …
-
84 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert
26 Jan 2025 22:55 GMT
… 40 mg manufactured by Windlas Biotech, Metoprolol Succinate Prolonged Release … Snikuf 4 manufactured by Akums Drugs and Pharmaceuticals, CIPRODAC 500 (Ciprofloxacin Tablets … of Preventive Medicine
& Research, Guindy, Chennai-32
66.
Ondansetron Tablets IP …
-
The Effect of Postoperative Tranexamic Acid and Dexamethasone on Quality of Recovery After Arthroscopic Rotator Cuff Repair: a Double-Blinded, Randomized Controlled Trial
20 Jan 2025 11:01 GMT
… personnel. The study medication [TXA (ReYoung Pharmaceutical Co., Ltd, … with 4 mg ondansetron was intravenously administered … pain treatment after total knee arthroplasty: randomised clinical trial. … -a randomized controlled trial. Drug Des Devel Ther. …
-
Royal Sense launches 10 new pharmaceutical products
14 Jan 2025 12:50 GMT
…
NDEM 4 MG Tablets: Ondansetron-based treatment for nausea and vomiting caused … spasms.
Focus Areas:
Category: Pharmaceuticals
Market: Domestic
Official Statement:
Rishabh … pharmaceutical portfolio.
The products aim to provide solutions for various medical …
-
AD04 for Alcohol Use Disorder: New Positive Results From Pharmacokinetics Study
29 Jan 2025 20:59 GMT
… and Drug Administration. They also conform with the FDA’ … the study confirmed that ondansetron pharmacokinetic exposure increased … alcohol consumption and make treatment for substance use … .
References
1. Adial Pharmaceuticals announces positive clinical study …
-
Research on Ondansetron and Sudden Cardiac Death Risk in Maintenance Hemodialysis Selected as Editors’ Choice by JASN
03 Jan 2025 19:50 GMT
… , associate professor of epidemiology, entitled “Ondansetron and the Risk of Sudden … reporting on kidney and renal medicine.
-
Effect of Ropivacaine Combined with Nalbuphine in Erector Spinae Plane Block on Postoperative Analgesia in Lumbar Trauma Surgery: A Single-Center Randomized Controlled Trial
03 Jan 2025 11:12 GMT
… is the primary surgical treatment for lumbar trauma; … vasoactive drugs (phenylephrine) were injected intravenously if necessary. Ondansetron ( … effects of adjuvant pharmaceutics to prolong the … double-blind, placebo-controlled trial. Medicine. 2021;100(32): …
-
Alcohol Use Disorder Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies By Delveinsight
02 Jan 2025 12:56 GMT
… medications approved by the US FDA for medication-assisted treatment … Pharmaceutical';s AD04 (ondansetron), Corcept Therapeutics' CORT118335 (miricorilant), Clearmind Medicine … trial for AUD treatment … trials, visit @
Alcohol Use Disorder Treatment Drugs …
About
© 1995-2025